NewsPronto

 
The Times


.

ACN Newswire

Read more press releases from ACN Newswire here

Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion

  • Written by ACN Newswire

image

HONG KONG, May 24, 2021 - (ACN Newswire) - Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2021.

Develo...

Read more: Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars...